Emotra AB is a research based medical device company. We offer the psychiatric care and objective and quantitative electrodermal test of hyporeactivity for the evaluation of suicide risk.


Introduction film
13 March

European Commission Horizon 2020 – application rejected

The European Commission, EC, has rejected Emotra’s application, submitted in…

Read more
15 February

Emotra AB (publ) Year-end report January 1 – December 31, 2016

The Board and CEO of Emotra AB herewith present the…

Read more
29 January

Emotra has submitted a new application for a grant from the EU Horizon 2020 programme

Emotra has submitted a new application to the European Commission…

Read more
30 November

Emotra’s application is given the “Seal of Excellence”

On November 28, Emotra announced that the Company’s Horizon 2020…

Read more
28 November

Future report dates for Emotra

Emotra’s Board of Directors has decided the following dates for…

Read more
28 November

European Commission Horizon 2020 – application rejected

The European Commission has rejected Emotra’s application for approximately 3…

Read more